IRIS CF acted as M&A advisor to the sole shareholder of Medistad Holding B.V. in the process of selling 100% of the shares. This process led to a sale to Pall.
Medistad offers product development and contract manufacturing of single-use products for applications in medical, pharmaceutical and biotechnology. The core competence of Medistad is high-tech plastic processing and engineering under clean room conditions. Medistad distinguishes itself in quality and innovation.
About Pall Corporation
Pall Corporation is a global leader in the high-tech filtration, separation, and purification industry by meeting the diverse needs of customers across the broad spectrum of life sciences and industry. Pall Corporation is listed on the New York Stock Exchange, a Fortune 1000 and S&P 500 company.